From owner-dros@hgmp.mrc.ac.uk Sun Oct 12 16:29:31 2003 Return-Path: X-Original-To: dros-outgoing Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with SMTP id 734057D32F for ; Sun, 12 Oct 2003 16:29:31 +0100 (BST) X-Original-To: dros-list@hgmp.mrc.ac.uk Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 098897D592 for ; Sun, 12 Oct 2003 16:29:31 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 6020) id D84057D32F; Sun, 12 Oct 2003 16:29:29 +0100 (BST) X-Original-To: bionet-drosophila@net.bio.net Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 4D3E07D296 for ; Thu, 9 Oct 2003 21:07:34 +0100 (BST) Received: by mercury.hgmp.mrc.ac.uk (Postfix, from userid 60001) id 0BE117D183; Thu, 9 Oct 2003 21:07:33 +0100 (BST) To: bionet-drosophila@net.bio.net From: kaufman@bio.indiana.edu (Thom Kaufman) Newsgroups: bionet.drosophila Subject: Exelixis EP Lines Organization: BIOSCI/MRC Human Genome Mapping Project Resource Centre Message-ID: <34DFE514-FA94-11D7-B3F9-000393671ED0@bio.indiana.edu> Mime-Version: 1.0 (Apple Message framework v552) Content-Type: multipart/alternative; boundary=Apple-Mail-20--623981535 X-Original-To: dros@net.bio.net X-Received: from localhost (localhost [127.0.0.1]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id 0A3CA7D326 for ; Thu, 9 Oct 2003 21:07:32 +0100 (BST) X-Received: from sunflower.bio.indiana.edu (unknown [156.56.96.143]) by mercury.hgmp.mrc.ac.uk (Postfix) with ESMTP id CB3867D183 for ; Thu, 9 Oct 2003 21:07:28 +0100 (BST) X-Received: from bio.indiana.edu (silkmoth.bio.indiana.edu [129.79.224.169]) by sunflower.bio.indiana.edu (8.12.10/8.12.10/biology-cgb) with ESMTP id h99K7RRs010950 for ; Thu, 9 Oct 2003 15:07:28 -0500 (EST) X-To: dros@net.bio.net X-Mailer: Apple Mail (2.552) Date: Sun, 12 Oct 2003 16:29:29 +0100 (BST) Sender: owner-dros@hgmp.mrc.ac.uk Precedence: bulk --Apple-Mail-20--623981535 Content-Transfer-Encoding: quoted-printable Content-Type: text/plain; charset=ISO-8859-1; format=flowed Exelixis EP Line Announcement Colleagues, We are in the process of consolidating the fly collection at Exelixis=20 and are working towards the goal of making larger numbers of our fly=20 stocks available to the not-for-profit Drosophila research community.=20 As part of this initiative, we will no longer serve as the US=20 distribution center for the Rorth collection EP stocks. To effect a=20 smooth transition, and to ensure that the most valuable stocks will=20 continue to be easily obtained by the fly community, we are=20 collaborating closely with both the Gene Disruption Project (GDP) and=20 the Bloomington Stock Center.=A0 As part of this process, the GDP has=20 analyzed the=A0genes tagged by the Rorth/EP collection, conducted=20 side-by-side comparisons with existing transposon tagged=A0lines, and = has=20 selected=A0400 stocks for retention at Bloomington.=A0 These stocks=A0tag=20= novel genes and were chosen to complement the increasing number of=20 insertion lines available through the efforts of the GDP=A0(see=20 http://flypush.imgen.bcm.tmc.edu/pscreen/).=A0 =A0We are=A0working = with=A0the=20 Bloomington Stock Center to facilitate the transfer of these stocks as=20= soon as possible. The entire=A0insertion collection, in addition to the = X=20 insertion lines already held at Bloomington,=A0is still available from=20= the Szeged center in Europe. If you have questions regarding insertions selected by the GDP, please=20= contact Hugo Bellen at hbellen@bcm.tmc.edu Any specific correspondence=20= for Exelixis may be directed to Helen Francis-Lang: helen@exelixis.com --Apple-Mail-20--623981535 Content-Transfer-Encoding: quoted-printable Content-Type: text/enriched; charset=ISO-8859-1
Exelixis EP Line Announcement
Times TimesColleagues,=20 We are in the process of consolidating the fly collection at Exelixis and are working towards the goal of making larger numbers of our fly stocks available to the not-for-profit Drosophila research community. As part of this initiative, we will no longer serve as the US distribution center for the Rorth collection EP stocks. To effect a smooth transition, and to ensure that the most valuable stocks will continue to be easily obtained by the fly community, we are collaborating closely with both the Gene Disruption Project (GDP) and the Bloomington Stock Center.=A0 As part of this process, the GDP has analyzed the=A0genes tagged by the Rorth/EP collection, conducted side-by-side comparisons with existing transposon tagged=A0lines, and has selected=A0400 stocks for retention = at Bloomington.=A0 These stocks=A0tag novel genes and were chosen to complement the increasing number of insertion lines available through the efforts of the GDP=A0(see = 1A1A,1A1A,FFFFhttp://flypush.imgen.bcm.tm= c.edu/pscreen/).=A0 =A0We are=A0working with=A0the Bloomington Stock Center to facilitate = the transfer of these stocks as soon as possible. The entire=A0insertion collection, in addition to the X insertion lines already held at Bloomington,=A0is still available from the Szeged center in Europe. If you have questions regarding insertions selected by the GDP, please contact Hugo Bellen at hbellen@bcm.tmc.edu Any specific correspondence for Exelixis may be directed to Helen Francis-Lang: helen@exelixis.com Times = --Apple-Mail-20--623981535-- --- .